Representative Sharice Davids Tours Local Medical Device Supplier Affected by Semiconductor Shortage, Calls for Supply Chain Solutions

Published in Government Relations on January 27, 2022

This message is shared on behalf of MAMES

This week, Representative Sharice Davids toured Cherub Medical Supplies, a Shawnee-based supplier of pediatric medical devices that is grappling with long delays due to the current shortage of critical materials like semiconductors. Davids joined Cherub and another local company, Lenexa-based Reliable Medical Supplies, to urge passage of legislation that would reduce our reliance on foreign-made materials and deliver these lifesaving devices to Kansans in need.

Rep. Sharice Davids speaks with Cherub Medical Supply Director of Operations Sam Cress.

(Rep. Sharice Davids speaks with Cherub Medical Supply Director of Operations Sam Cress.)

“These local businesses are doing their best to work around supply chain issues and get lifesaving machines to the children and adults who are dependent on them to stay healthy, but we can be doing more to help them,” said Davids. “I’m working to get legislation like the CHIPS Act across the finish line so that we can strengthen our domestic supply chain, lower costs, and make these critical materials here at home.”
 
Semiconductors, or chips, are necessary components of many medical devices, including the CPAP machines provided by Cherub and Reliable to over 72,000 sleep apnea patients in the Kansas Third District. The current global chip shortage has contributed to inflation on goods from cars to smartphones—and to a growing waitlist for lifesaving medical devices. Cherub works primarily with kids who need these machines to return home safely from the hospital, supplying home medical equipment such as oxygen monitors and ventilators. Reliable serves over 800 clients in the Kansas City area, including nursing homes.
 
“As a small business caring for medically fragile children in Kansas City, we have faced many issues due to rising costs, semiconductor supply chain shortages, and declining reimbursement. We look forward to partnering with Rep. Davids regarding these concerns to champion and protect the families we serve,” said Sam Cress, Director of Operations at Cherub Medical Supply.
 
Davids has been a vocal proponent of the bipartisan CHIPS Act, which would boost domestic manufacturing of these critical materials and reduce our dependence on foreign-made goods. It currrently awaits full funding through the U.S. Innovation and Competition Act, which has been passed by the House and the Senate. If funded, it would provide $52 billion to strengthen domestic semiconductor production, including $2 billion targeted to the research and development of mature node semiconductors, known as legacy chips, which are critical for medical devices, smartphones, cars, computers, and more.
 
“As a local provider of home medical equipment, we are experiencing unprecedented interruptions as we try to provide for our patients. The shortage of semiconductor chips has meant long backorders for equipment and uneasy delivery times for our patients.  We look forward to working with Rep. Davids and her colleagues on the Hill to find ways to remedy this situation,” said Nick Hulsing, Owner of Reliable Medical Supply.
 
Davids has been actively working to reduce global supply chain issues and lower costs for businesses and consumers. She introduced the SUPPLIES Act, which create a $100 million grant program for small and medium manufacturers that shift their production to manufacture PPE and testing supplies during future public health emergencies. It would also prioritize manufacturing these supplies domestically, reducing our country’s dependence on foreign countries for medical supplies and eliminating price gouging of life-saving materials. 

Rep. Sharice Davids tours Cherub Medical Supply in Shawnee, Kansas

(Rep. Sharice Davids tours Cherub Medical Supply in Shawnee, Kansas)


TAGS

  1. state association
  2. supply chain
  3. vgm government

From Our Experts

CMS Releases CPI-U Adjustments for DMEPOS In 2026 And Fee Schedule Q1 thumbnail CMS Releases CPI-U Adjustments for DMEPOS In 2026 And Fee Schedule Q1 The Centers for Medicare & Medicaid Services (CMS) released the annual inflation factor to be applied to DMEPOS items effective January 1, 2026, with an implementation date of January 5, 2026. The breakdown of the adjustment is dependent upon whether the serviced items are included in the competitive bidding program (CBP) or are in formerly competitive bid areas (CBAs) such as rural and non-rural. Update from the Board of Certification/Accreditation thumbnail Update from the Board of Certification/Accreditation Yesterday, the Board of Certification/Accreditation (BOC) issued a clarification regarding the Centers for Medicare & Medicaid's (CMS) recent announcement about withdrawing BOC Accreditation. Here are the key updates... CMS Withdraws BOC Accreditation Authority For DMEPOS Suppliers thumbnail CMS Withdraws BOC Accreditation Authority For DMEPOS Suppliers On December 2, 2025, the Centers for Medicare & Medicaid Services (CMS) officially revoked the Board of Certification/Accreditation International (BOC) as an approved accreditation organization for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). The DMEPOS Competitive Bid Program (CBP) And The New Remote Item Delivery Competitive Bidding Program – What Suppliers Need To Know thumbnail The DMEPOS Competitive Bid Program (CBP) And The New Remote Item Delivery Competitive Bidding Program – What Suppliers Need To Know A major development to come out of the CMS DMEPOS/Home Health Final Rule is the creation of a new Remote Item Delivery (RID) competitive bid program (CBP). This article provides the key items DMEPOS suppliers need to be aware of regarding this significant development in the competitive bidding program. CMS Changes Accreditation Requirements For All DMEPOS Suppliers Effective January 1, 2026. thumbnail CMS Changes Accreditation Requirements For All DMEPOS Suppliers Effective January 1, 2026. As we shared last week, CMS finalized the DMEPOS accreditation rule change that requires Accrediting Organizations (AOs) to survey and recredential DMEPOS suppliers annually, instead of every three years. This change is outside of competitive bidding and applies to all DMEPOS suppliers as a condition of Medicare enrollment. FAQs from the Webinar: Understanding the Final Rule on the DMEPOS Competitive Bidding Program thumbnail FAQs from the Webinar: Understanding the Final Rule on the DMEPOS Competitive Bidding Program Thank you to everyone who joined last week's webinar! We've compiled the most frequently asked questions from the session along with updated answers to help you stay informed. Major Update On Product Categories For The Next Round Of Competitive Bidding thumbnail Major Update On Product Categories For The Next Round Of Competitive Bidding Since the publication of the Final Rules on the Competitive Bidding Program (CBP) was announced, VGM has been in conversation with CMS officials as well as other industry groups regarding additional products being included into the CBP. The unofficial feedback we received indicated that there would be no additional products beyond those reported in the Final Rule. CMS Finalizes Rule Changing The Next Round Of The Competitive Bidding Program And Updating Other Provisions Related To Provider Enrollment And Prior Authorization thumbnail CMS Finalizes Rule Changing The Next Round Of The Competitive Bidding Program And Updating Other Provisions Related To Provider Enrollment And Prior Authorization Final Rule Analysis from the VGM Payer Relations and Reimbursement team  On Nov, 28, 2025, CMS finalized Final Rule CMS-1828-F that includes updates to the Competitive Bidding Program (CBP) and other provisions related to provider enrollment and prior authorization. Next round is expected to be implemented no later than Jan. 1, 2028.